Lucinda Billingham

University of Birmingham - Cancer Research Clinical Trials Unit

Lucinda Billingham BSc MSc PhD CStat
Lucinda Billingham is Professor of Biostatistics within the Institute of Cancer and Genomic Sciences at the University of Birmingham. She has worked for over twenty years as a Biostatistician at their Cancer Research UK Clinical Trials Unit and is now Director of Biostatistics for the Unit working with a large team of Biostatisticians on an extensive portfolio of early and late phase trials. Lucinda has a special interest in lung cancer research and is the Chief Biostatistician for the National Lung Matrix Trial. She is a member of the British Thoracic Oncology Group Steering Committee and is an invited member of the Cancer Research UK Clinical Expert Review Panel providing statistical advice for funding applications. She lectures on a number of undergraduate and postgraduate courses at Birmingham, teaches widely on external courses and provides PhD supervision.

dont miss

National Lung Matrix Trial: testing multiple novel targeted treatments

The National Lung Matrix Trial (NLMT) is a flagship trial in the United Kingdom being the first to combine the development of a technology platform that screens for multiple genetic aberrations in lung tumours (provided by the Cancer Research UK Stratified Medicine Programme) with testing of multiple novel genetic-marker-directed drugs. This presentation will summarise the challenges encountered with design, implementation and reporting of this umbrella-basket phase II platform trial.

EVEN MORE SEMINARS

  • Lucy Thompson ft. Stacie-rae Weir: Speaking at the Oncology Convention

    Lucy Thompson ft. Stacie-rae Weir
    Nipple Innovation Project

    Healing power of permanent realism in restorative tattooing

  • Professor Robert Thomas: Speaking at the Oncology Convention

    Professor Robert Thomas
    Bedford and Addenbrooke's Cambridge University Hospitals

    Evidence based lifestyle strategies after cancer - a research review

  • MR. KELVIN K.W LAU: Speaking at the Oncology Convention

    MR. KELVIN K.W LAU
    Barts Health NHS Trust

    IMAGE GUIDANCE FOR BRONCHOSCOPY AND LUNG SURGERY

  • Anders Johnsson: Speaking at the Oncology Convention

    Anders Johnsson
    Scandinavian ChemoTech AB

    Dynamic-ElectroEnhanced Chemotherapy brings relief to palliative patients with a large tumour burden

  • Dr Margaret Wexler: Speaking at the Oncology Convention

    Dr Margaret Wexler
    Breast Cancer UK

    How can we prevent breast cancer?